ClinicalTrials.Veeva

Menu

Protector™ Versus Supreme® Laryngeal Mask Airway

S

Schulthess Klinik

Status

Completed

Conditions

Anesthesia

Treatments

Device: Protector
Device: Supreme

Study type

Interventional

Funder types

Other

Identifiers

NCT03214497
Schulthess_Anä_11

Details and patient eligibility

About

The goal of this study is to compare the oropharyngeal leak pressure of the Protector Laryngeal mask with the Supreme laryngeal mask. Other secondary parameters will be studied.

Full description

The OLP as the primary outcome measurement will be evaluated after insertion of the LMA in each group. We hypothesize that there will be a difference of 4 cm H2O between the 2 masks, because of the different material and slightly different form of the masks. Secondary outcomes will be measured after insertion of the LMA as by protocol. Finally postoperative airway morbidity will be evaluated 3 hours after removal of the LMA.

Enrollment

96 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18-75
  • ASA 1-3
  • Operation on limbs
  • written informed consent

Exclusion criteria

  • known difficult airway
  • anatomical abnormalities on airway, Larynx, oesophagus, stomach
  • not fastened
  • high aspiration risk
  • patients with contraindication of laryngeal mask
  • BMI >35 kg/m2
  • patients with disease which impairs accurate Investigation of patient
  • cardiovascular risk factors
  • COPD
  • acute disease where anaesthesia is in doubt
  • no written consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

96 participants in 2 patient groups, including a placebo group

Protector group
Active Comparator group
Description:
All patients collocated randomly to the Protector Group Primary and secondary outcome Parameters are studied
Treatment:
Device: Protector
Supreme group
Placebo Comparator group
Description:
All patients collocated randomly to the Supreme Group, Primary and secondary outcome Parameters are studied
Treatment:
Device: Supreme

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems